NVNO — ENVVENO MEDICAL CORPORATION

Ownership history in XTX Topco Ltd  ·  5 quarters on record

This page tracks every 13F SEC filing in which XTX Topco Ltd reported a position in ENVVENO MEDICAL CORPORATION (NVNO). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.01% (2023 Q4)
Avg. % of fund
0.0%
First filed
2023 Q4
Last filed
2025 Q4
Quarters held
5
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 ADDED 67,187 +25,145 +59.8% 0.00% $22K $11.23
2025 Q3 ADDED 42,042 +24,415 +138.5% 0.00% $38K $31.71
2025 Q2 REDUCED 17,627 -12,810 -42.1% 0.00% $70K $139.65
2025 Q1 ADDED 30,437 +19,148 +169.6% 0.00% $80K $92.05
2023 Q4 INITIATED 11,289 — — 0.01% $58K —
% of Fund (quarterly)    NVNO price (monthly, adj. close)

Other funds also holding NVNO

As of 2025 Q4 — sorted by position size

CM Management, LLC 3Y 0.34% KINGDON CAPITAL MANAGEMENT, L.L.C. 3Y 7Y 0.05% PERCEPTIVE ADVISORS LLC 3Y 7Y 0.01% GSA CAPITAL PARTNERS LLP 3Y 7Y 0.01% Westside Investment Management, Inc. 3Y 7Y 0.0% TWO SIGMA SECURITIES, LLC 3Y 7Y 0.0% Fermata Advisors, LLC 3Y 0.0% Virtu Financial LLC 3Y 7Y 0.0% TWO SIGMA INVESTMENTS, LP 3Y 7Y 0.0% HRT FINANCIAL LP 3Y 7Y 0.0%
← Back to XTX Topco Ltd Holdings